Evidence map›Paper›PMID 34221094›Full record

ReviewEvidence-based complementary and alternative medicine : eCAM2021

The Therapeutic Potential of Wogonin Observed in Preclinical Studies.

Javad Sharifi-Rad, Jesús Herrera-Bravo, Luis A Salazar, Shabnum Shaheen, Seyed Abdulmajid Ayatollahi, Farzad Kobarfard, Muhammad Imran, Ali Imran, Luísa Custódio, María Dolores López and 5 more

RetractedAbstract readReviewRetracted Publication
In one paragraph

Review in Evidence-based complementary and alternative medicine : eCAM, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Wogonin inhibits hepatoma cell proliferation by targeting miR-27b-5p/YWHAZ axis.Journal of biochemical and molecular toxicology · 2023
    Article
  9. Article
  10. Review
  11. Article
  12. Wogonin, as a potent anticancer compound: From chemistry to cellular interactions.Experimental biology and medicine (Maywood, N.J.) · 2023
    Review
  13. Autophagy Induction byPharmaceuticals (Basel, Switzerland) · 2023
    Review
  14. Review
  15. Article
  16. Retracted: The Therapeutic Potential of Wogonin Observed in Preclinical Studies.Evidence-based complementary and alternative medicine : eCAM · 2023
    Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Javad Sharifi-RadPhytochemistry Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.ORCID https://orcid.org/0000-0002-7301-8151
Jesús Herrera-BravoDepartamento de Ciencias Básicas, Facultad de Ciencias, Universidad Santo Tomas, Santiago, Chile.
Luis A SalazarCenter of Molecular Biology and Pharmacogenetics, Scientific and Technological Bioresource Nucleus, Universidad de La Frontera, Temuco 4811230, Chile.
Shabnum ShaheenDepartment of Plant Sciences, LCWU, Lahore 54000, Pakistan.
Seyed Abdulmajid AyatollahiPhytochemistry Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Farzad KobarfardPhytochemistry Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Muhammad ImranUniversity Institute of Diet and Nutritional Sciences, Faculty of Allied Health Sciences, The University of Lahore, Lahore, Pakistan.
Ali ImranDepartment of Food Science, Nutrition & Home Economics, Institute of Home and Food Sciences Government College University, Faisalabad, Pakistan.
Luísa CustódioCentre of Marine Sciences, University of Algarve, Faculty of Sciences and Technology, Building 7, Campus of Gambelas, Faro 8005-139, Portugal.
María Dolores LópezDepartment of Plant Production, Faculty of Agronomy, Universidad de Concepción, Avenida Vicente Mendez, 595, Chillán 3812120, Chile.
Mauricio SchoebitzDepartamento de Suelos y Recursos Naturales, Facultad de Agronomía, Universidad de Concepción, Concepción, Chile.
Miquel MartorellDepartment of Nutrition and Dietetics, Faculty of Pharmacy, and Centre for Healthy Living, University of Concepción, Concepción 4070386, Chile.ORCID https://orcid.org/0000-0003-3183-7623
Manoj KumarChemical and Biochemical Processing Division, ICAR-Central Institute for Research on Cotton Technology, Mumbai 400019, India.ORCID https://orcid.org/0000-0002-4192-6497
Hafiz Ansar Rasul SuleriaDepartment of Agriculture and Food Systems, The University of Melbourne, Melbourne 3010, Australia.
William C ChoDepartment of Clinical Oncology, Queen Elizabeth Hospital, Kowloon, Hong Kong.ORCID https://orcid.org/0000-0003-4174-4586

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Wogonin is a flavonoid found in different plants such as roots of

Identifiers

PMID34221094
PMCPMC8221866

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.